Cost-Minimization Analysis of Once-Weekly Versus Thrice-Weekly Epoetin Alfa for Chemotherapy-Related Anemia

BACKGROUND: For individuals with chemotherapy-related anemia, the clinical effectiveness of epoetin alfa (EPO) dosed once weekly ([QW], 40,000 units per dose) has been demonstrated to be indistinguishable from that observed with thrice-weekly dosing ([TIW], 10,000 units per dose). Whether the advant...

Descripción completa

Detalles Bibliográficos
Autores principales: Cremieux, Pierre Y., Fastenau, John M., Kosicki, George, Piech, Catherine T., Fendrick, A. Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2004
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438224/
https://www.ncbi.nlm.nih.gov/pubmed/15548125
http://dx.doi.org/10.18553/jmcp.2004.10.6.531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438224/
https://www.ncbi.nlm.nih.gov/pubmed/15548125
http://dx.doi.org/10.18553/jmcp.2004.10.6.531

Ejemplares similares